Literature DB >> 29355500

Influenza Hemifusion Phenotype Depends on Membrane Context: Differences in Cell-Cell and Virus-Cell Fusion.

Katarzyna E Zawada1, Kenta Okamoto2, Peter M Kasson3.   

Abstract

Influenza viral entry into the host cell cytoplasm is accomplished by a process of membrane fusion mediated by the viral hemagglutinin protein. Hemagglutinin acts in a pH-triggered fashion, inserting a short fusion peptide into the host membrane followed by refolding of a coiled-coil structure to draw the viral envelope and host membranes together. Mutations to this fusion peptide provide an important window into viral fusion mechanisms and protein-membrane interactions. Here, we show that a well-described fusion peptide mutant, G1S, has a phenotype that depends strongly on the viral membrane context. The G1S mutant is well known to cause a "hemifusion" phenotype based on experiments in transfected cells, where cells expressing G1S hemagglutinin can undergo lipid mixing in a pH-triggered fashion similar to virus but will not support fusion pores. We compare fusion by the G1S hemagglutinin mutant expressed either in cells or in influenza virions and show that this hemifusion phenotype occurs in transfected cells but that native virions are able to support full fusion, albeit at a slower rate and 10-100× reduced infectious titer. We explain this with a quantitative model where the G1S mutant, instead of causing an absolute block of fusion, alters the protein stoichiometry required for fusion. This change slightly slows fusion at high hemagglutinin density, as on the viral surface, but at lower hemagglutinin density produces a hemifusion phenotype. The quantitative model thus reproduces the observed virus-cell and cell-cell fusion phenotypes, yielding a unified explanation where membrane context can control the observed viral fusion phenotype.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  fusion peptide; hemifusion; influenza virus; membrane fusion; stoichiometry

Mesh:

Substances:

Year:  2018        PMID: 29355500      PMCID: PMC5831491          DOI: 10.1016/j.jmb.2018.01.006

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

1.  Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.

Authors:  X Han; J H Bushweller; D S Cafiso; L K Tamm
Journal:  Nat Struct Biol       Date:  2001-08

2.  Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.

Authors:  M Ohuchi; A Cramer; M Vey; R Ohuchi; W Garten; H D Klenk
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.

Authors:  K J Cross; S A Wharton; J J Skehel; D C Wiley; D A Steinhauer
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

4.  Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.

Authors:  Esmeralda Alvarado-Facundo; Yamei Gao; Rosa María Ribas-Aparicio; Alicia Jiménez-Alberto; Carol D Weiss; Wei Wang
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

5.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

Review 6.  Composition and functions of the influenza fusion peptide.

Authors:  Karen J Cross; William A Langley; Rupert J Russell; John J Skehel; David A Steinhauer
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

7.  Single-particle kinetics of influenza virus membrane fusion.

Authors:  Daniel L Floyd; Justin R Ragains; John J Skehel; Stephen C Harrison; Antoine M van Oijen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

8.  Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.

Authors:  T Danieli; S L Pelletier; Y I Henis; J M White
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

9.  Lipid tail protrusion in simulations predicts fusogenic activity of influenza fusion peptide mutants and conformational models.

Authors:  Per Larsson; Peter M Kasson
Journal:  PLoS Comput Biol       Date:  2013-03-07       Impact factor: 4.475

10.  The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin.

Authors:  Bargavi Thyagarajan; Jesse D Bloom
Journal:  Elife       Date:  2014-07-08       Impact factor: 8.140

View more
  7 in total

1.  Detecting and Controlling Dye Effects in Single-Virus Fusion Experiments.

Authors:  Robert J Rawle; Ana M Villamil Giraldo; Steven G Boxer; Peter M Kasson
Journal:  Biophys J       Date:  2019-07-02       Impact factor: 4.033

2.  2H nuclear magnetic resonance spectroscopy supports larger amplitude fast motion and interference with lipid chain ordering for membrane that contains β sheet human immunodeficiency virus gp41 fusion peptide or helical hairpin influenza virus hemagglutinin fusion peptide at fusogenic pH.

Authors:  Ujjayini Ghosh; David P Weliky
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-06-23       Impact factor: 3.747

3.  The Stabilities of the Soluble Ectodomain and Fusion Peptide Hairpins of the Influenza Virus Hemagglutinin Subunit II Protein Are Positively Correlated with Membrane Fusion.

Authors:  Ahinsa Ranaweera; Punsisi U Ratnayake; David P Weliky
Journal:  Biochemistry       Date:  2018-09-05       Impact factor: 3.162

4.  Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms.

Authors:  Anna Pabis; Robert J Rawle; Peter M Kasson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-18       Impact factor: 11.205

5.  Precise Triggering and Chemical Control of Single-Virus Fusion within Endosomes.

Authors:  Sourav Haldar; Kenta Okamoto; Rebecca A Dunning; Peter M Kasson
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

Review 6.  Cell Fusion-Related Proteins and Signaling Pathways, and Their Roles in the Development and Progression of Cancer.

Authors:  Hao Zhang; Hong Ma; Xiaohui Yang; Linlin Fan; Shifeng Tian; Rui Niu; Man Yan; Minying Zheng; Shiwu Zhang
Journal:  Front Cell Dev Biol       Date:  2022-02-01

7.  Early Virus-Host Cell Interactions.

Authors:  Pierre-Yves Lozach
Journal:  J Mol Biol       Date:  2018-06-30       Impact factor: 5.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.